Dana Investment Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,606
Closed -$379K 423
2023
Q2
$379K Sell
2,606
-1,552
-37% -$211K 0.02% 344
2023
Q1
$537K Sell
4,158
-42
-1% -$5.27K 0.03% 303
2022
Q4
$536K Buy
4,200
+1
+0% +$116 0.03% 303
2022
Q3
$439K Sell
4,199
-339
-7% -$37.2K 0.02% 324
2022
Q2
$477K Sell
4,538
-960
-17% -$114K 0.02% 318
2022
Q1
$703K Sell
5,498
-7,009
-56% -$845K 0.03% 241
2021
Q4
$1.54M Sell
12,507
-109,148
-90% -$14.3M 0.07% 178
2021
Q3
$17.3M Sell
121,655
-1,456
-1% -$214K 0.78% 50
2021
Q2
$19.2M Buy
123,111
+4,858
+4% +$787K 0.85% 48
2021
Q1
$18.4M Buy
+118,253
New +$18.3M 0.85% 49

Other funds holding ZBH

Dana Investment Advisors's ZBH Position: Q3 2023 in Review

Dana Investment Advisors sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 2,606 shares — an estimated $379K sold.

Dana Investment Advisors first reported a position in ZBH in Q1 2021 and held it in 10 quarters. The position peaked at $19.2M in Q2 2021. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • Dana Investment Advisors reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
  • Dana Investment Advisors sold 2,606 Zimmer Biomet shares in Q3 2023, an estimated $379K.
  • Dana Investment Advisors first reported a position in Zimmer Biomet in Q1 2021 and held it in 10 quarters.
  • Dana Investment Advisors's Zimmer Biomet position peaked at $19.2M in Q2 2021.
  • 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Dana Investment Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.